TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18029165

Group type: EXPERIMENTAL
Intervention: FENO measurement using NIOX MINO®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FENO measurement for asthma management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FENO measurement for asthma management in severe population
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard diagnostics
Number of subjects: 0
Study: 16836070

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Blunt dissection tonsillectomy
Number of subjects: 56
Study: 12832959

Group type: EXPERIMENTAL
Intervention: Abstinence with transdermal nicotine patch (25 mg per day)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Abstinence with placebo patch
Number of subjects: 78

Group type: COMPARATOR
Intervention: Continuous smoking
Number of subjects: 78

Group type: COMPARATOR
Intervention: Never-smokers
Number of subjects: 78
Study: 10800878

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 7
Study: 8849265

Group type: EXPERIMENTAL
Intervention: Subcutaneous rhG‐CSF (lenograstim, 2 micrograms per kg of body weight per day)
Number of subjects: 12
Study: 1462489

Group type: EXPERIMENTAL
Intervention: Vaginally administered estriol at a dose of 0.01 g daily for 3 weeks, and 0.01 g bi‐weekly for a further 3 weeks
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Vaginally administered estriol
Number of subjects: 629
Study: 30326906

Group type: EXPERIMENTAL
Intervention: Self-management exercise program + spa therapy (5 sessions of self-management exercise, 18 sessions of spa therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information booklet + spa therapy (18 sessions of spa therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-management exercise program + spa therapy
Number of subjects: 0
Study: 27756268

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) training for nominated staff, peer support service establishment, training for additional teachers, mental health awareness session for all teachers.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual practice in comparison schools.
Number of subjects: 0
Study: 24813833

Group type: EXPERIMENTAL
Intervention: Pain bias condition (threatening interpretation of pain)
Number of subjects: 106

Group type: COMPARATOR
Intervention: No pain bias condition (nonthreatening interpretation of pain)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Threat condition (threatening information regarding the cold pressor)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Reassuring condition (reassuring information regarding the cold pressor)
Number of subjects: 106
Study: 22569484

Group type: EXPERIMENTAL
Intervention: 60 μg vaccine
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: 120 μg vaccine
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: 200 μg vaccine
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study: 20353751

Group type: EXPERIMENTAL
Intervention: Reference formulation (20 mg leflunomide)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Test formulation (20 mg leflunomide)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 24
Study: 18300351

Group type: EXPERIMENTAL
Intervention: Treatment of H pylori-positive patients and all H pylori-positive family members (group I)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment of H pylori-positive patients only (group II)
Number of subjects: 70
Study: 15935245

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 0
Study: 12566476

Group type: EXPERIMENTAL
Intervention: CHO Group (Carbohydrate Group) consuming a diet with a CHO/protein ratio of 3.5 (68 g protein/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protein Group consuming a diet with a CHO/protein ratio of 1.4 (125 g protein/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both groups (CHO and Protein)
Number of subjects: 24
Study: 10588963

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 59
Study: 9346692

Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2) at 5 ng/kg/minute
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) at 0.1 microgram/kg/minute
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control interval (no drug)
Number of subjects: 15
Study: 1678797

Group type: EXPERIMENTAL
Intervention: Multimodal therapy (laxatives plus behaviour modification)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Behaviour modification alone
Number of subjects: 169
Study: 6192747

Group type: EXPERIMENTAL
Intervention: Cisplatinum, methotrexate, bleomycin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Oncovin, methotrexate, bleomycin
Number of subjects: 77
Study: 30579763

Group type: COMPARATOR
Intervention: 6 months of androgen suppression plus radiotherapy (6AS+RT)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: 18 months of androgen suppression plus radiotherapy (18AS+RT)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (18 months)
Number of subjects: 1071

Group type: COMPARATOR
Intervention: No zoledronic acid
Number of subjects: 1071
Study: 29161369

Group type: EXPERIMENTAL
Intervention: Pace-capture-guided ablation along a contact-force-guided isolation line
Number of subjects: 156

Group type: COMPARATOR
Intervention: Contact-force-guided PV isolation ablation alone (control group)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Pace-capture-guided ablation
Number of subjects: 156
Study: 27825009

Group type: EXPERIMENTAL
Intervention: Anakinra (2 mg/kg per day, up to 100 mg for 2 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 21
Study: 24188873

Group type: EXPERIMENTAL
Intervention: Long GnRH agonist
Number of subjects: 111

Group type: COMPARATOR
Intervention: Short GnRH agonist
Number of subjects: 111

Group type: COMPARATOR
Intervention: GnRH antagonist
Number of subjects: 111
Study: 23244163

Group type: EXPERIMENTAL
Intervention: 3 hour psychoeducational intervention focusing on sleep
Number of subjects: 214

Group type: COMPARATOR
Intervention: Set of booklets (control group)
Number of subjects: 214
Study: 21180275

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (routine Ringer's solution)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 16804519

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 6111

Group type: COMPARATOR
Intervention: Not treated (NRT)
Number of subjects: 6111
Study: 12693876

Group type: EXPERIMENTAL
Intervention: FT+ (Feeling Thermometer with hypothetical marker states)
Number of subjects: 84

Group type: COMPARATOR
Intervention: FT- (Feeling Thermometer without hypothetical marker states)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: SG+ (Standard Gamble with hypothetical marker states)
Number of subjects: 84

Group type: COMPARATOR
Intervention: SG- (Standard Gamble without hypothetical marker states)
Number of subjects: 84
Study: 11885168

Group type: EXPERIMENTAL
Intervention: Bar‐supported overdenture (maxillary completely edentulous)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Cap‐retained overdenture (maxillary completely edentulous)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Screw‐retained hybrid denture (mandibular completely edentulous)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Cap‐retained prosthesis (mandibular completely edentulous)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Screw‐retained fixed partial denture (mandibular posterior partially edentulous)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Screw‐retained fixed partial denture (maxillary posterior partially edentulous)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: Cemented single crown (maxillary anterior single tooth)
Number of subjects: 687
Study: 9398894

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg + Amoxicillin 1 gm + Clarithromycin 500 mg (OAC500)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg + Metronidazole 400 mg + Clarithromycin 250 mg (OMC250)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg + Metronidazole 400 mg + Clarithromycin 500 mg (OMC500)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg + Amoxicillin 1 gm + Clarithromycin 250 mg (OAC250)
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg + Amoxicillin 1 gm + Metronidazole 400 mg (OAM)
Number of subjects: 787

Group type: COMPARATOR
Intervention: Omeprazole 20 mg + Placebo (OP)
Number of subjects: 787
Study: 1575550

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3872061

Group type: EXPERIMENTAL
Intervention: 60:40 whey/casein formula
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate preparation
Number of subjects: 15

Group type: COMPARATOR
Intervention: 20:80 whey/casein formula
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Higher protein intake formulas (4.3 g/kg/day and 4.4 g/kg/day)
Number of subjects: 15
Study: 31149913

Group type: EXPERIMENTAL
Intervention: Early endotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-and-see policy
Number of subjects: 20
Study: 27112124

Group type: EXPERIMENTAL
Intervention: Gist Reasoning Training
Number of subjects: 50

Group type: COMPARATOR
Intervention: New Learning
Number of subjects: 50
Study: 25767938

Group type: EXPERIMENTAL
Intervention: 3D laparoscope
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2D laparoscope
Number of subjects: 20
Study: 24062326

Group type: EXPERIMENTAL
Intervention: Fixed meal dosing
Number of subjects: 126

Group type: COMPARATOR
Intervention: Flexible meal dosing
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 126
Study: 22029980

Group type: EXPERIMENTAL
Intervention: Briakinumab (200 mg at weeks 0 and 4, 100 mg at week 8 and every 4 weeks thereafter)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Methotrexate (5 to 25 mg weekly)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Briakinumab
Number of subjects: 317

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 317
Study: 19507267

Group type: EXPERIMENTAL
Intervention: Far Infrared Ray (FIR) stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heat Pad (HP) therapy
Number of subjects: 0
Study: 16937305

Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin (CDDP) at 30 mg/m(2) for weekly schedule
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin (CDDP) at 50 mg/m(2) for monthly schedule
Number of subjects: 45
Study: 15632875

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 3755
Study: 11598313

Group type: EXPERIMENTAL
Intervention: Clioquinol 20 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clioquinol 80 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clioquinol (both dosages)
Number of subjects: 20
Study: 9531122

Group type: EXPERIMENTAL
Intervention: Continuous-flow cold therapy for 3 days, then as needed for days 4-7.
Number of subjects: 100
Study: 8021330

Group type: EXPERIMENTAL
Intervention: Diclofenac dispersible 50 mg
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 257
Study: 2783753

Group type: COMPARATOR
Intervention: Retransfusion of oxygenator blood after termination of extracorporeal circulation (Group I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Processing of oxygenator content by means of a cell separator (Group II)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Predonation of autologous blood and isovolumetric substitution of hydroxyethyl starch (10 ml/kg bodyweight) after induction of anesthesia plus cell separator (Group III)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Predonation and use of a cell separator plus postoperative retransfusion of shed mediastinal blood (Group IV)
Number of subjects: 100
Study: 1194660

Group type: EXPERIMENTAL
Intervention: Outreach services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free medical care + Outreach services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free medical care
Number of subjects: 0
Study: 31113400

Group type: EXPERIMENTAL
Intervention: Attentive eating smartphone application along with standard dietary advice
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard dietary advice only
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Attentive eating smartphone application
Number of subjects: 107
Study: 28130726

Group type: EXPERIMENTAL
Intervention: Psychoeducation (9 weeks, group intervention)
Number of subjects: 60
Study: 25452447

Group type: EXPERIMENTAL
Intervention: CBT-I plus armodafinil (A)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: CBT-I plus placebo (P)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Armodafinil (A) alone
Number of subjects: 96
Study: 23129814

Group type: EXPERIMENTAL
Intervention: Surface neuromuscular electrical stimulation (30-minute sessions) and physiotherapy (45 minutes)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (physiotherapy for 45 minutes)
Number of subjects: 90
Study: 21968267

Group type: EXPERIMENTAL
Intervention: Radioactive iodine therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 17559710

Group type: EXPERIMENTAL
Intervention: Anodal tDCS of the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Anodal tDCS of the occipital cortex (active control)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS (placebo control)
Number of subjects: 40
Study: 16864930

Group type: EXPERIMENTAL
Intervention: Carvedilol plus ACEI (n=13)
Number of subjects: 28

Group type: COMPARATOR
Intervention: ACEI only (n=15)
Number of subjects: 28
Study: 12518131

Group type: EXPERIMENTAL
Intervention: Rectal tube insertion
Number of subjects: 157

Group type: COMPARATOR
Intervention: No rectal tube insertion
Number of subjects: 157
Study: 11737118

Group type: EXPERIMENTAL
Intervention: OKT3/MMF/delayed Neoral/prednisone
Number of subjects: 54

Group type: COMPARATOR
Intervention: MMF/immediate Neoral/prednisone without OKT3
Number of subjects: 54
Study: 9416409

Group type: EXPERIMENTAL
Intervention: Intraoperative photodynamic therapy (PDT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No intraoperative photodynamic therapy (no PDT)
Number of subjects: 63
Study: 8440925

Group type: EXPERIMENTAL
Intervention: Esophageal disease associated with specific pathologic processes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Detection of HIV‐1 mRNA
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Presence of HIV‐1 in esophageal mucosa
Number of subjects: 25
Study: 3359863

Group type: EXPERIMENTAL
Intervention: Differential reinforcement for the use of foreign vocabulary
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nondifferential reinforcement for use of the native language or the foreign language
Number of subjects: 0
Study: 31605493

Group type: EXPERIMENTAL
Intervention: Daily doses of rhEPO combined with iron supplement starting 3 days before surgery (Group A)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Daily doses of rhEPO combined with iron supplement starting the day of surgery (Group B)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Iron supplement alone (Group C)
Number of subjects: 102
Study: 29095982

Group type: EXPERIMENTAL
Intervention: 40 U insulin spray
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 80 U insulin spray
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 160 U insulin spray
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 28399621

Group type: EXPERIMENTAL
Intervention: GAE plus ball game group (BG group; N=30)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: GAE plus square-stepping exercise group (SSE group; N=28)
Number of subjects: 102

Group type: COMPARATOR
Intervention: General aerobic exercise (GAE) group (N=44)
Number of subjects: 102
Study: 24430881

Group type: EXPERIMENTAL
Intervention: Tailored multimedia education in addition to usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 22990092

Group type: COMPARATOR
Intervention: GHRH + Pl
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: GHRH + T
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: saline + T
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: SS + T
Number of subjects: 21

Group type: COMPARATOR
Intervention: saline + Pl
Number of subjects: 21

Group type: COMPARATOR
Intervention: SS + Pl
Number of subjects: 21
Study: 21041815

Group type: EXPERIMENTAL
Intervention: 1 L of clear apple juice
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1 L of clear apple juice without polyphenols (placebo)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1 L of cloudy apple juice (positive control)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1 L of water (negative control)
Number of subjects: 12
Study: 17524030

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg, single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 16
Study: 16248381

Group type: EXPERIMENTAL
Intervention: Technetium‐99m DTPA aerosol inhalation scintigraphy
Number of subjects: 25
Study: 11888095

Group type: EXPERIMENTAL
Intervention: 10 microg levonorgestrel
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: 20 microg levonorgestrel
Number of subjects: 163

Group type: COMPARATOR
Intervention: Sequential oral medroxyprogesterone acetate (5mg/day, 14/30 days)
Number of subjects: 163
Study: 9457265

Group type: EXPERIMENTAL
Intervention: Classification and Regression Trees (CART)
Number of subjects: 885

Group type: EXPERIMENTAL
Intervention: Multiple logistic regression
Number of subjects: 885

Group type: EXPERIMENTAL
Intervention: Level of consciousness (LOC)
Number of subjects: 885

Group type: COMPARATOR
Intervention: Single best performing prognostic factor (level of consciousness)
Number of subjects: 885
Study: 8580273

Group type: EXPERIMENTAL
Intervention: Erythromycin 500 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 2636645

Group type: EXPERIMENTAL
Intervention: Limited protein intake (12% of energy)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Usual protein intake (19% of energy)
Number of subjects: 8
Study: 89854

Group type: EXPERIMENTAL
Intervention: shea butter
Number of subjects: 0

Group type: COMPARATOR
Intervention: xylometazoline (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: white petroleum jelly B.P. (placebo)
Number of subjects: 0
Study: 31794673

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Environment (IVE) exergaming (Fruit Ninja)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-Immersive Virtual Environment (non-IVE) exergaming (Fruit Ninja)
Number of subjects: 33
Study: 31412864

Group type: EXPERIMENTAL
Intervention: Video feedback and e-Learning
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no video feedback)
Number of subjects: 28
Study: 28351201

Group type: EXPERIMENTAL
Intervention: Active electroconvulsive therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham electroconvulsive therapy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 27
Study: 24817417

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg for two subcutaneous injections at a 15-day interval
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 23635672

Group type: COMPARATOR
Intervention: General text messages encouraging general pregnancy health
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Text messages encouraging general pregnancy health plus influenza vaccination
Number of subjects: 204
Study: 20652288

Group type: EXPERIMENTAL
Intervention: 400 μg oral misoprostol
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 400 μg sublingual misoprostol
Number of subjects: 93
Study: 20298399

Group type: EXPERIMENTAL
Intervention: Compliance enhancement training (CET) with salmeterol/fluticasone propionate
Number of subjects: 361

Group type: COMPARATOR
Intervention: Medication alone (salmeterol/fluticasone propionate)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Both groups (CET and medication alone)
Number of subjects: 361
Study: 17219388

Group type: EXPERIMENTAL
Intervention: RT-PCR positive sentinel node
Number of subjects: 39

Group type: COMPARATOR
Intervention: RT-PCR negative sentinel node
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: RT-PCR positive versus RT-PCR negative
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: RT-PCR of the sentinel node
Number of subjects: 39
Study: 16621879

Group type: EXPERIMENTAL
Intervention: Torasemide (4‐8 mg/day; n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Furosemide (20‐40 mg/day; n = 20)
Number of subjects: 40
Study: 14500052

Group type: EXPERIMENTAL
Intervention: Cluster randomization design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual randomization design
Number of subjects: 0
Study: 10360914

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive containing 20 microg of ethinylestradiol with 75 microg of gestodene for three cycles
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control cycle (before treatment)
Number of subjects: 26
Study: 7857145

Group type: EXPERIMENTAL
Intervention: Stapled anastomoses
Number of subjects: 732

Group type: COMPARATOR
Intervention: Sutured anastomoses
Number of subjects: 732
Study: 1937993

Group type: EXPERIMENTAL
Intervention: Nifecard (10 mg capsules)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Adalat (10 mg capsules)
Number of subjects: 12
Study: 6814596

Group type: EXPERIMENTAL
Intervention: Transaxial tomoscintigraphy using iodine‐131‐labelled monoclonal antibodies against carcinoembryonic antigen
Number of subjects: 17

Group type: COMPARATOR
Intervention: Rectilinear scintigraphy
Number of subjects: 17
Study: 30607616

Group type: EXPERIMENTAL
Intervention: p-CREB level
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no significant cognitive impairment)
Number of subjects: 107